Structural analysis and serological test of arginine periplasmic binding protein 2 from Chlamydophila pneumoniae

Biochemical and Biophysical Research Communications

Volumn 418, Issue 3, 2012, Pages 518-524

  Park, Sung Ha ^a,b   Chang, Ji Eun ^a   Hawkes, Hye Jin Kim ^c   Kang, Yeon Ho ^b   Hwang, Kwang Yeon ^a  

^a Korea University   (South Korea)

^b Korea Centers for Disease Control and Prevention   (South Korea)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

Arginine periplasmic binding protein 2; Chlamydophila pneumoniae; Diagnosis; Immunogenic antigen; Serological test; Structural analysis

Indexed keywords

ARGININE PERIPLASMIC BINDING PROTEIN 2; BACTERIAL PROTEIN; PERIPLASMIC BINDING PROTEIN; PROTEIN HISTIDINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; STRUCTURE ANALYSIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; ARGININE; BACTERIAL PROTEINS; CELL LINE; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CRYSTALLOGRAPHY, X-RAY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GENES, REGULATOR; HUMANS; MOLECULAR SEQUENCE DATA; PERIPLASMIC BINDING PROTEINS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PNEUMONIAE TW-183; LEGIONELLA PNEUMOPHILA; MYCOPLASMA PNEUMONIAE;

EID: 84863150814     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.058     Document Type: Article

References (37)

1. Caldara M., Minh P.N., Bostoen S., Massant J., Charlier D. Argr-dependent repression of arginine and histidine transport genes in Escherichia coli K-12. J. Mol. Biol. 2007, 373:251-267.
2. Caldara M., Charlier D., Cunin R. The arginine regulon of escherichia coli: whole-system transcriptome analysis discovers new genes and provides an integrated view of arginine regulation. Microbiology 2006, 152:3343-3354.
3. Grayston J.T., Campbell L.A., Kuo C.C., Mordhorst C.H., Saikku P., Thom D.H., Wang S.P. A new respiratory tract pathogen: Chlamydia Pneumoniae strain Twar. J. Infect. Dis. 1990, 161:618-625.
4. Hahn D.L., Golubjatnikov R. Asthma and chlamydial infection: a case series. J. Fam. Pract. 1994, 38:589-595.
5. Mukhopadhyay S., Good D., Miller R.D., Graham J.E., Mathews S.A., Timms P., Summersgill J.T. Identification of Chlamydia pneumoniae proteins in the transition from reticulate to elementary body formation. Mol. Cell Proteomics 2006, 5:2311-2318.
6. Kumar S., Hammerschlag M.R. Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin. Infect. Dis. 2007, 44:568-576.
7. Amin A.S. Application of touchdown enzyme time release (tetr)-PCR for diagnosis of Chlamydophila abortus infection. Res. Vet. Sci. 2003, 74:213-217.
8. Mitchell S.L., Budhiraja S., Thurman K.A., Lanier Thacker W., Winchell J.M. Evaluation of two real-time pcr chemistries for the detection of Chlamydophila pneumoniae in clinical specimens. Mol. Cell Probes. 2009, 23:309-311.
9. Dowell S.F., Peeling R.W., Boman J., Carlone G.M., Fields B.S., Guarner J., Hammerschlag M.R., Jackson L.A., Kuo C.C., Maass M., Messmer T.O., Talkington D.F., Tondella M.L., Zaki S.R. Standardizing Chlamydia pneumoniae assays: recommendations from the centers for disease control and prevention (USA) and the laboratory centre for disease control (Canada). Clin Infect Dis. 2001, 33:492-503.
10. Van Der Heide T., Poolman B. ABC transporters: one two or four extracytoplasmic substrate-binding sites. EMBO Rep. 2002, 10:938-943.
11. Fleischer R., Wengner A., Scheffel F., Landmesser H., Schneider E. Identification of a gene cluster encoding an arginine atp-binding-cassette transporter in the genome of the thermophilic gram-positive bacterium Geobacillus stearothermophilus strain DSMZ 13240. Microbiology 2005, 151:835-840.
12. A. Tvinnereim, B. Wizel, CD8+ T Cell protective immunity against Chlamydia pneumoniae includes an H2-M3-restricted response that is largely CD4+ T cell-independent, J. Immunol. 179 (2007) 3947-3957.
13. Finco O., Bonci A., Agnusdei M., Scarselli M., Petracca R., Norais N., Ferrari G., Garaguso I., Donati M., Sambri V., Cevenini R., Ratti G., Grandi G. Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings. Vaccine. 2005, 23:1178-1188.
14. Mukhopadhyay S., Clark A.P., Sullivan E.D., Miller R.D., Summersgill J.T. Detailed protocol for purification of Chlamydia pneumoniae elementary bodies. J. Clin. Microbiol. 2004, 42:3288-3290.
15. Tondella M.L., Talkington D.F., Holloway B.P., Dowell S.F., Cowley K., Soriano-Gabarro M., Elkind M.S., Fields B.S. Development and evaluation of real-time pcr-based fluorescence assays for detection of Chlamydia pneumoniae. J. Clin. Microbiol. 2002, 40:575-583.
16. Miller E.M., Nickoloff J.A. Escherichia coli electrotransformation. Methods Mol. Biol. 1995, 47:105-113.
17. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997, 276:307-326.
18. Soriani M., Petit P., Grifantini R., Petracca R., Gancitano G., Frigimelica E., Nardelli F., Garcia C., Spinelli S., Scarabelli G., Fiorucci S., Affentranger R., Ferrer-Navarro M., Zacharia M., Colombo G., Vuillard L., Daura W., Grandi G. Exploiting antigenic diversity for vaccine design: the chlamydia artj paradigm. J. Biol. Chem. 2010, 285:30126-30138.
19. Brunger A.T., Adams P.D., Clore G.M., Delano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., Read R.J., Rice L.M., Simonson T., Warren G.L. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol. Crystallogr. 1998, 54:905-921.
20. Murshudov G.N., Vagin A.A., Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 1997, 53:240-255.
21. Adams Pd P.D., Afonine P.V., Bunkoczi G., Chen V.B., Davis I.W., Echols N., Headd J.J., Hung L.W., Kapral G.J., Grosse-Kunstleve R.W., Mccoy A.J., Moriarty N.W., Oeffner R., Read R.J., Richardson D.C., Richardson J.S., Terwilliger T.C., Zwart P.H. Phenix: a comprehensive python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 2010, 66:213-221.
22. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004, 60:2126-2132.
23. W. Delano, The Pymol Molecular Graphics System, Http://www.pymolorg. 1998-2003.
24. Park S.H., Kwon S.J., Lee S.J., Kim Y.C., Hwang K.Y., Kang Y.H., Lee K.J. Identification of immunogenic antigen candidate for Chlamydophila pneumoniae diagnosis. J. Proteome Res. 2009, 8:2933-2943.
25. A. Burillo, E. Bouza, Chlamydophila Pneumoniae, Infect. Dis. Clin. North Am. 24 (2010) 61-71.
26. J. Lenart, A.A. Andersen, D.D. Rockey, Growth and development of tetracycline-resistant Chlamydia suis. Antimicrob. Agents Chemother. 45 (2001) 2198-2203.
27. Song J.H., Oh W.S., Kang C.I., Chung D.R., Peck K.R., Ko K.S., Yeom J.S., Kim C.K., Kim S.W., Chang H.H., Kim Y.S., Jung S.I., Tong Z., Wang Q., Huang S.G., Liu J.W., Lalitha M.K., Tan B.H., Van P.H., Carlos C.C. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the asian network for surveillance of resistant pathogens. Int. J. Antimicrob. Agents. 2008, 31:107-114.
28. Tormakangas L., Markkula E., Lounatmaa K., Puolakkainen M. Chlamydia pneumoniae infection in polarized epithelial cell lines. Infect. Immun. 2010, 78:2714-2722.
29. Turgeman Y., Levahar P., Lavi I., Shneor A., Colodner R., Samra Z., Bloch L., Rosenfeld T. Adult calcific aortic stenosis and Chlamydia pneumoniae: the role of chlamydia infection in valvular calcification. Isr. Med. Assoc. J. 2006, 8:464-468.
30. Cunha B.A. The atypical pneumonias: clinical diagnosis and importance. Clin. Microbiol. Infect. 2006, 12:12-24.
31. Von H.L. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae. Eur. Respir. J. 2002, 19:546-556.
32. Wissenbach U., Six S., Bongaerts J., Ternes D., Steinwachs S., Unden G. A third periplasmic transport system for l-arginine in Escherichia coli: molecular characterization of the artPIQMJ genes, arginine binding and transport. Mol. Microbiol. 1995, 17:675-686.
33. West A.H., Stock A.M. Histidine kinases and response regulator proteins in two-component signaling systems. Trends Biochem. Sci. 2001, 26:369-376.
34. Cheung J., Le-Khac M., Hendrickson W.A. Crystal structure of a histidine kinase sensor domain with similarity to periplasmic binding proteins. Proteins. 2009, 77:235-241.
35. Niemhom S., Pongkun C., Petkanchanapong W., Chintrakarn C. Evaluation of direct immunofluorescence test for diagnosis of upper respiratory tract infection by Chlamydia pneumoniae. J. Med. Assoc. Thai. 2008, 91:1416-1424.
36. Sueur J.M., Beaumont K., Cabioch T., Orfila J., Betsou F. Diagnostic value of an elisa using a recombinant 54-kda species-specific protein from Chlamydia pneumoniae. Clin. Microbiol. Infect. 2006, 12:470-477.
37. Bunk S., Susnea I., Rupp J., Summersgill J.T., Maass M., Stegmann W., Schrattenholz A., Wendel A., Przybylski M., Hermann C. Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections. J. Immunol. 2008, 180:5490-5498.